Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization

BACKGROUND: The aim of this study was to evaluate the efficacy of intravitreal bevacizumab when administered on an as-needed basis for the treatment of myopic choroidal neovascularization (CNV), and to assess visual changes upon treatment. METHODS: This study was designed as a retrospective, interve...

Descripción completa

Detalles Bibliográficos
Autores principales: Milani, Paolo, Massacesi, Amedeo, Ciaccia, Stefano, Setaccioli, Marco, Moschini, Stefania, Bergamini, Fulvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508741/
https://www.ncbi.nlm.nih.gov/pubmed/23204830
http://dx.doi.org/10.2147/OPTH.S34649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508741/
https://www.ncbi.nlm.nih.gov/pubmed/23204830
http://dx.doi.org/10.2147/OPTH.S34649

Ejemplares similares